Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2012 | 03-2011 | 03-2010 | 03-2009 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,990 | 5,831 | 4,788 | 1,785 | 2,042 |
| Marketable Securities | 71,233 | 54,481 | 53,477 | 55,394 | 36,257 |
| Receivables | 20,458 | 15,376 | 13,516 | 15,724 | 14,071 |
| Inventories | 11,142 | 7,505 | 9,211 | 14,777 | 17,428 |
| TOTAL | $110,539 | $84,737 | $82,668 | $88,489 | $71,503 |
| Non-Current Assets | |||||
| PPE Net | 6,378 | 6,273 | 6,753 | 7,792 | 7,551 |
| Investments And Advances | 0 | 0 | 0 | 3,721 | 0 |
| Intangibles | 36,846 | 40,578 | 40,149 | 35,654 | 38,484 |
| Other Non-Current Assets | 148 | 0 | 0 | 302 | 493 |
| TOTAL | $43,372 | $46,851 | $46,902 | $47,469 | $46,528 |
| Total Assets | $153,911 | $131,588 | $129,570 | $135,958 | $118,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,910 | 6,283 | 3,764 | 5,550 | 9,024 |
| Accrued Expenses | 12,480 | 14,078 | 13,011 | 10,818 | 9,290 |
| TOTAL | $22,415 | $22,343 | $18,064 | $17,579 | $19,476 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,025 | 1,982 | 1,289 | 1,211 | 1,162 |
| Other Non-Current Liabilities | 400 | 492 | 510 | 310 | 221 |
| TOTAL | $5,199 | $4,502 | $3,550 | $2,396 | $4,961 |
| Total Liabilities | $27,614 | $26,845 | $21,614 | $19,975 | $24,437 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,383 | 38,483 | 37,433 | 37,351 | 32,957 |
| Common Shares | 393 | 377 | 375 | 367 | 328 |
| Retained earnings | -273,275 | -274,770 | -263,015 | -243,991 | -212,394 |
| Other shareholders' equity | -1,592 | 918 | -829 | -1,490 | 4,873 |
| TOTAL | $126,297 | $104,743 | $107,956 | $115,983 | $93,594 |
| Total Liabilities And Equity | $153,911 | $131,588 | $129,570 | $135,958 | $118,031 |